192 related articles for article (PubMed ID: 22767316)
1. Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph.
Becker N; Schnitzler P; Boffetta P; Brennan P; Foretova L; Maynadié M; Nieters A; Staines A; Benavente Y; Cocco P; de Sanjose S
J Cancer Res Clin Oncol; 2012 Dec; 138(12):1993-2001. PubMed ID: 22767316
[TBL] [Abstract][Full Text] [Related]
2. [An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma].
Liu WP; Zheng W; Wang XP; Song YQ; Xie Y; Tu MF; Lin NJ; Ping LY; Ying ZT; Deng LJ; Zhang C; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):521-4. PubMed ID: 22338173
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
4. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma.
Zhou X; Pan H; Yang P; Ye P; Cao H; Zhou H
BMC Cancer; 2019 May; 19(1):477. PubMed ID: 31113483
[TBL] [Abstract][Full Text] [Related]
5. Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.
Li Z; Guo W; Zhao Y; Wang H; Guo J; Li Z; Wang B; Cao L; Xu J; Young KH; Bai O
Cancer Med; 2024 May; 13(10):e7284. PubMed ID: 38752442
[TBL] [Abstract][Full Text] [Related]
6. Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin's lymphoma.
Zhou X; Wuchter P; Egerer G; Kriegsmann M; Kommoss FKF; Witzens-Harig M; Kriegsmann K
Eur J Haematol; 2020 May; 104(5):469-475. PubMed ID: 31961011
[TBL] [Abstract][Full Text] [Related]
7. Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
Rossi G; Pelizzari A; Motta M; Puoti M
Br J Haematol; 2001 Oct; 115(1):58-62. PubMed ID: 11722410
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
Visentini M; Pica A; D'Ippolito G; Sculco E; La Gualana F; Gragnani L; Miglionico M; Mazzaro C; Fiorilli M; Basili S; Martelli M; Di Rocco A; Casato M; Gentile G; Pulsoni A
Ann Hematol; 2023 Dec; 102(12):3457-3463. PubMed ID: 37650886
[TBL] [Abstract][Full Text] [Related]
9. Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Franceschi S; Lise M; Trépo C; Berthillon P; Chuang SC; Nieters A; Travis RC; Vermeulen R; Overvad K; Tjønneland A; Olsen A; Bergmann MM; Boeing H; Kaaks R; Becker N; Trichopoulou A; Lagiou P; Bamia C; Palli D; Sieri S; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Peeters PH; Rodríguez L; Barroso LL; Dorronsoro M; Sánchez MJ; Navarro C; Barricarte A; Regnér S; Borgquist S; Melin B; Hallmans G; Khaw KT; Wareham N; Rinaldi S; Hainaut P; Riboli E; Vineis P
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):208-14. PubMed ID: 21098651
[TBL] [Abstract][Full Text] [Related]
10. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.
Wang F; Xu RH; Han B; Shi YX; Luo HY; Jiang WQ; Lin TY; Huang HQ; Xia ZJ; Guan ZZ
Cancer; 2007 Apr; 109(7):1360-4. PubMed ID: 17326056
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
[TBL] [Abstract][Full Text] [Related]
12. Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma.
Loglio A; Viganò M; Grossi G; Labanca S; Goldaniga M; Pompa A; Farina L; Rumi M; Corradini P; Facchetti F; Lunghi G; Baldini L; Lampertico P
Dig Liver Dis; 2019 Mar; 51(3):419-424. PubMed ID: 30316785
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy.
Taborelli M; Polesel J; Montella M; Libra M; Tedeschi R; Battiston M; Spina M; Di Raimondo F; Pinto A; Crispo A; Grimaldi M; Franceschi S; Dal Maso L; Serraino D
Infect Agent Cancer; 2016; 11():27. PubMed ID: 27340429
[TBL] [Abstract][Full Text] [Related]
14. Characterization of hepatitis B virus infection and viral DNA integration in non-Hodgkin lymphoma.
Li M; Shen Y; Chen Y; Gao H; Zhou J; Wang Q; Fan C; Zhang W; Li J; Cong H; Gu J; Gan Y; Tu H
Int J Cancer; 2020 Oct; 147(8):2199-2209. PubMed ID: 32350851
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies.
Dalia S; Chavez J; Castillo JJ; Sokol L
Leuk Res; 2013 Sep; 37(9):1107-15. PubMed ID: 23809055
[TBL] [Abstract][Full Text] [Related]
16. Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapy.
Chen J; Wang J; Yang J; Zhang W; Song X; Chen L
PLoS One; 2013; 8(7):e69400. PubMed ID: 23861969
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus and risk of non-Hodgkin lymphoma: An updated meta-analysis of 58 studies.
Li M; Gan Y; Fan C; Yuan H; Zhang X; Shen Y; Wang Q; Meng Z; Xu D; Tu H
J Viral Hepat; 2018 Aug; 25(8):894-903. PubMed ID: 29532605
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis virus B and C infections are associated with an increased risk of non-Hodgkin lymphoma: A nested case-control study using a national sample cohort.
Kim M; Lee YK; Park B; Oh DJ; Choi HG
J Med Virol; 2020 Aug; 92(8):1214-1220. PubMed ID: 31825111
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis.
Nath A; Agarwal R; Malhotra P; Varma S
Intern Med J; 2010 Sep; 40(9):633-41. PubMed ID: 19811561
[TBL] [Abstract][Full Text] [Related]
20. Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection.
Yang HC; Tsou HH; Pei SN; Chang CS; Chen JH; Yao M; Lin SJ; Lin J; Yuan Q; Xia N; Liu TW; Chen PJ; Cheng AL; Hsu C;
J Hepatol; 2018 Aug; 69(2):286-292. PubMed ID: 29551710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
